Prenetics Global Limited (NASDAQ:PRE – Get Rating) shares traded down 24.4% during mid-day trading on Thursday . The company traded as low as $1.24 and last traded at $1.70. 548,995 shares changed hands during trading, an increase of 1,667% from the average session volume of 31,061 shares. The stock had previously closed at $2.25.
Prenetics Global Stock Down 24.4 %
The business has a fifty day moving average price of $3.25.
Get
Prenetics Global alerts:
Prenetics Global (NASDAQ:PRE – Get Rating) last released its quarterly earnings results on Friday, September 9th. The company reported $0.04 earnings per share for the quarter. The business had revenue of $51.72 million during the quarter. Analysts anticipate that Prenetics Global Limited will post -2.99 earnings per share for the current year.
Institutional Trading of Prenetics Global
A hedge fund recently bought a new stake in Prenetics Global stock. NINE MASTS CAPITAL Ltd purchased a new stake in Prenetics Global Limited (NASDAQ:PRE – Get Rating) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 49,949 shares of the company's stock, valued at approximately $202,000. NINE MASTS CAPITAL Ltd owned approximately 0.11% of Prenetics Global as of its most recent SEC filing.
About Prenetics Global
(Get Rating)
Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test.
Further Reading
- Get a free copy of the StockNews.com research report on Prenetics Global (PRE)
- Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
- Is the 60/40 Portfolio Mix Still in Vogue?
- Microsoft Shares: Is it Time to Back Up the Truck?
- Three CBD Stocks to Dominate a Budding Industry
- Institutional Support for Analog Devices Remains High
Receive News & Ratings for Prenetics Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prenetics Global and related companies with MarketBeat.com's FREE daily email newsletter.
Prenetics Global Limited (NASDAQ:PRE – Get Rating) shares traded down 24.4% during mid-day trading on Thursday . The company traded as low as $1.24 and last traded at $1.70. 548,995 shares changed hands during trading, an increase of 1,667% from the average session volume of 31,061 shares. The stock had previously closed at $2.25.
Prenetics Global Limited（納斯達克股票代碼：PRE — Get Rating）股價在週四午盤交易中下跌了24.4％。該公司的交易價格低至1.24美元，最後一次交易價格爲1.70美元。548,995股在交易期間易手，較平均交易量31,061股增長了1,667％。該股此前曾收於2.25美元。
Prenetics Global Stock Down 24.4 %
The business has a fifty day moving average price of $3.25.
Get
Prenetics Global
alerts:
Prenetics Global (NASDAQ:PRE – Get Rating) last released its quarterly earnings results on Friday, September 9th. The company reported $0.04 earnings per share for the quarter. The business had revenue of $51.72 million during the quarter. Analysts anticipate that Prenetics Global Limited will post -2.99 earnings per share for the current year.
Prenetics Global（納斯達克股票代碼：PRE — Get Rating）最後一次發佈季度業績是在9月9日星期五。該公司公佈本季度每股收益爲0.04美元。該業務在本季度的收入爲5172萬美元。分析師預計，Prenetics Global Limited今年的每股收益將爲-2.99。
Institutional Trading of Prenetics Global
A hedge fund recently bought a new stake in Prenetics Global stock. NINE MASTS CAPITAL Ltd purchased a new stake in Prenetics Global Limited (NASDAQ:PRE – Get Rating) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 49,949 shares of the company's stock, valued at approximately $202,000. NINE MASTS CAPITAL Ltd owned approximately 0.11% of Prenetics Global as of its most recent SEC filing.
一家對沖基金最近購買了Prenetics Global股票的新股份。據該公司在美國證券交易委員會的最新披露中稱，NINE MASTS CAPITAL Ltd在第二季度收購了Prenetics Global Limited（納斯達克股票代碼：PRE — Get Rating）的新股份。該公司購買了該公司49,949股股票，價值約20.2萬美元。截至美國證券交易委員會最近提交的文件時，NINE MASTS CAPITAL Ltd擁有Prenetics Global約0.11％的股份。
About Prenetics Global
Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test.
Prenetics Global Limited是一家投資控股公司，是一家診斷和基因檢測公司。其產品包括消費者基因檢測產品CircleDNA；以及Circle HealthPod，這是一種快速檢測健康監測系統，允許用戶利用核酸擴增測試在醫療點或家中進行 COVID-19 檢測。
Further Reading
- Get a free copy of the StockNews.com research report on Prenetics Global (PRE)
- Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
- Is the 60/40 Portfolio Mix Still in Vogue?
- Microsoft Shares: Is it Time to Back Up the Truck?
- Three CBD Stocks to Dominate a Budding Industry
- Institutional Support for Analog Devices Remains High
- 免費獲取 StockNews.com 關於 Prenetics Global (PRE) 的研究報告的副本
- Salesforce裁員，儘管面臨挑戰，但收入仍表現強勁
- 60/40 的投資組合還在流行嗎？
- 微軟股票：是時候備份卡車了嗎？
- 三隻CBD股票將在新興行業中佔據主導地位
- 機構對模擬設備的支持仍然很高
Receive News & Ratings for Prenetics Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prenetics Global and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Prenetics 全球日報的新聞和評級 -在下面輸入您的電子郵件地址，即可通過Marketbeat.com的免費每日電子郵件時事通訊接收Prenetics Global及相關公司的最新新聞和分析師評級的簡明每日摘要。
